Yvon Elkrim
Brussels, BRU, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Pan-cancer single-cell atlases of mouse and human tumor-associated dendritic cells.
Journal: Nature communications
Published: November 12, 2025
A fast-progressing orthotopic ovarian cancer model reveals synergistic antitumor effects of AXL-targeting nanobodies and Olaparib.
Journal: Gynecologic oncology reports
Published: September 04, 2025
VSIG4 Is Dispensable for Tumor Growth and Metastasis in Murine Colorectal and Breast Cancer Models.
Journal: Cancers
Published: August 22, 2025
VSIG4-Expressing Macrophages Contribute to Antiparasitic and Antimetastatic Responses in the Peritoneal Cavity.
Journal: European journal of immunology
Published: January 15, 2025
Depleting IL1R2+ Tumor-Infiltrating Regulatory T Cells with an ADCC-Prone Nanobody Construct Boosts the Efficacy of Anti-PD-1 Immunotherapy.
Journal: Cancer research
Published: August 27, 2024
Infection history imprints prolonged changes to the epigenome, transcriptome and function of Kupffer cells.
Journal: Journal of hepatology
Published: August 03, 2023
Flt3L therapy increases the abundance of Treg-promoting CCR7+ cDCs in preclinical cancer models.
Journal: Frontiers in immunology
Published: February 14, 2023
Junctional adhesion molecule-A is dispensable for myeloid cell recruitment and diversification in the tumor microenvironment.
Journal: Frontiers in immunology
Published: July 26, 2022
Intrabody Targeting HIF-1α Mediates Transcriptional Downregulation of Target Genes Related to Solid Tumors.
Journal: International journal of molecular sciences
Published: October 16, 2021
Macrophages are metabolically heterogeneous within the tumor microenvironment.
Journal: Cell reports
Published: June 04, 2021
Last Updated: 09/26/2026